Welcome to the final episode of VJHemOnc’s Blood Cancer Awareness Month special series!

This episode focuses on the role of artificial intelligence (AI) in personalizing blood cancer care. Carsten Niemann, MD, PhD, Copenhagen University Hospital, Copenhagen, Denmark, discusses the value of AI in hematological oncology and how it is currently used in the clinic. He then shares details of a treatment infection model for chronic lymphocytic leukemia (CLL) that has been deployed in his institution. Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone, New York City, NY, delves into the role of AI in the classification of multiple myeloma and the prediction of patients who will need transplantation. He also touches on the use of AI to better understand genomic data.

References

Niemann C, Levin M-D, Österborg A, et al. The CLL Treatment Infection Model – Clinical Prospective Validation as Part of the Prevent-Acall Trial. Hemasphere. 2023;7(Suppl):e1432517.

The post A focus on the use of artificial intelligence to personalize blood cancer care appeared first on VJHemOnc.